The TGFβ cytokine superfamily and receptor-activated mothers against decapentaplegic homologue (SMAD) cascades are the core components of TGFβ signaling, which is universally dysregulated in various types of malignancies, including GBM. The gene discussed is TGFB1; the disease is glioblastoma.